Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



POWELL MICHAEL Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 POWELL MICHAEL (Director) has filed a Form 4 on Galera Therapeutics, Inc.
Txns: Granted 64,000 options to buy @ $3.27, valued at $209.3k
06/16/2022 4 POWELL MICHAEL (Director) has filed a Form 4 on Galera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $1.48, valued at $29.6k
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 POWELL MICHAEL (Director) has filed a Form 4 on Galera Therapeutics, Inc.
Txns: Granted 13,179 options to buy @ $8.9, valued at $117.3k
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/09/2021 4 Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Converted 1,104,209 shares @ $0
Converted 1,200,228 shares @ $0
Bought 450,000 shares @ $20, valued at $9M
Converted 1,104,209 preferred shares @ $0
Converted 1,200,228 preferred shares @ $0
02/04/2021 3 Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 3 on Bolt Biotherapeutics, Inc.
11/12/2020 4 POWELL MICHAEL (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Granted 30,000 options to buy @ $10.95, valued at $328.5k
08/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/06/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/10/2020 4 POWELL MICHAEL (10% Owner) has filed a Form 4 on Galera Therapeutics, Inc.
Txns: Granted 13,179 options to buy @ $9.31, valued at $122.7k
06/03/2020 4 Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc
Txns: Sold 100,000 shares @ $1.6912, valued at $169.1k
Sold 400,000 shares @ $1.6074, valued at $643k
01/23/2020 4 Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc
Txns: Granted options to buy @ $1750000, valued at $0
11/19/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/08/2019 4 POWELL MICHAEL (10% Owner) has filed a Form 4 on Galera Therapeutics, Inc.
Txns: Granted 19,776 options @ $12, valued at $237.3k
11/06/2019 3 Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Galera Therapeutics, Inc.
06/07/2019 4 POWELL MICHAEL (Director) has filed a Form 4 on SYNLOGIC, INC.
Txns: Granted 10,000 options to buy @ $7.3, valued at $73k
05/15/2019 4 Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on NextCure, Inc.
Txns: Converted 278,759 shares @ $0
Converted 464,599 shares @ $0
Converted 908,785 shares @ $0
Converted 469,713 shares @ $0
Bought 400,000 shares @ $15, valued at $6M
Converted 2,239,500 preferred shares @ $0
Converted 3,732,500 preferred shares @ $0
Converted 7,301,000 options to buy @ $0
Converted 3,773,585 preferred shares @ $0
05/08/2019 3 Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on NextCure, Inc.
10/02/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/25/2018 3 Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc.
09/20/2018 4 Sofinnova Venture Partners VIII, L.P. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.
Txns: Converted 625,482 shares @ $0
Converted 521,235 shares @ $0
Converted 453,954 shares @ $0
Converted 167,537 shares @ $0
Bought 270,000 shares @ $17, valued at $4.6M
Converted 625,482 preferred shares @ $0
Converted 521,235 preferred shares @ $0
Converted 453,954 options to buy @ $0
Converted 167,537 preferred shares @ $0
09/13/2018 3 Sofinnova Venture Partners VIII, L.P. (10% Owner) has filed a Form 3 on Principia Biopharma Inc.
06/14/2018 4 POWELL MICHAEL (Director) has filed a Form 4 on SYNLOGIC, INC.
Txns: Granted 10,000 options to buy @ $9.36, valued at $93.6k
05/30/2018 4 Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc
Txns: Converted 721,408 shares @ $0
Converted 275,446 shares @ $0
Converted 229,660 shares @ $0
Bought 500,000 shares @ $13, valued at $6.5M
Converted 721,408 options to buy @ $0
Converted 275,446 options to buy @ $0
Converted 229,660 options to buy @ $0
05/24/2018 3 Sofinnova Venture Partners IX, L.P. (10% Owner) has filed a Form 3 on Iterum Therapeutics plc
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy